Barely Significant
← all excerpts

Rituximab Administration to Treat Nephrotic Syndrome in Children: 2-Year Follow-Up.

Biomedicines · 2024 · PMC11592163 · PMID 39595166

Europe PMCDOI
3
hedged sentences
0.4965
closest p · 9.9× alpha
0.4965
boldest claim

The sentences

did not reach statistical significancep = 0.496515not close (p > 0.1)
Despite this fluctuation, the overall eGFR improvement in SRNS patients did not reach statistical significance ( p = 0.496515).

also in 111,027 other papers

a positive trendno p-value reported
However, a positive trend was noted in 72.2% of cases by the end of the treatment year (as shown in Table 3 ).

also in 11,005 other papers

highly significantno p-value reported
The p -value for ACR reduction in SSNS was 0.000036, confirming a highly significant response to RTX therapy.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.